Released on = June 18, 2007, 5:23 pm

Press Release Author = GTCbio

Industry = Pharmaceuticals

Press Release Summary = Michael J. Donovan, Senior Vice President, Research
Collaborations at Aureon Biosciences Corporation will give a presentation entitled
“The Future of Predictive Testing” at GTCbio’s Targeted Designs for Clinical Trials
Conference on July 19 – 20, 2007 in Philadelphia, PA.

Press Release Body = Michael J. Donovan, Senior Vice President, Research
Collaborations at Aureon Biosciences Corporation will give a presentation entitled
“The Future of Predictive Testing” at GTCbio’s Targeted Designs for Clinical Trials
Conference on July 19 – 20, 2007 in Philadelphia, PA.

The talk will discuss the utilization of integrated ‘system’ based approaches in
building oncology based predictive and prognostic models for clinical decision
making and therapeutic trials. Donovan will also address recent successes in
biological and drug-targeted therapeutic discovery programs as well as challenges in
bringing predictive tests results to the clinic.

GTCbio’s Targeted Designs for Clinical Trials Conference will take place at The
Downtown Club on the 11th floor of Philadelphia’s Historic Public Ledger Building.
The meeting addresses strategies to accelerate drug development, lower trial costs
and reduce development risks.

For more information including a detailed agenda, exhibitor opportunities and
registration information visit
http://www.gtcbio.com/conference/conferenceDetails.aspx?id

Web Site = http://www.gtcbio.com

Contact Details = GTCbio organizes conferences specifically for the biomedical and
biopharmaceutical industries. Our goal is to facilitate the exchange of
biopharmaceutical and biomedical intelligence between industry leaders, academic and
government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, christy.bowman@gtcbio.com